ENGERIX B 20 microgrammes/1 mL, suspension injectable en seringue préremplie. Vaccin de l'hépatite B (ADNr), (adsorbé) (VHB) — 1 seringue(s) préremplie(s) en verre de 1 ml avec aiguille(s)
Medicine package · Base de données publique des médicaments (BDPM), ANSM, HAS et Assurance Maladie · France
-
CIP13
3400935166906 -
CIP7
3516690 -
CIS
62279329
What the source publishes
- Holder
- GLAXOSMITHKLINE
- Active ingredients
- ANTIGÈNE DE SURFACE DE L'HÉPATITE B RECOMBINANT
- Form
- suspension injectable
- Package
- 1 seringue(s) préremplie(s) en verre de 1 ml avec aiguille(s)
- Routes
- intramusculaire, sous-cutanée
- Administrative status
- authorised
- Supply regime
- liste I
- Marketing status
- Déclaration de commercialisation
- Authorised on
- 1994-12-30
- Prescription
- Prescription or restricted
Names this record is found by
- ENGERIX B 20 microgrammes/1 mL, suspension injectable en seringue préremplie. Vaccin de l'hépatite B (ADNr), (adsorbé) (VHB) — 1 seringue(s) préremplie(s) en verre de 1 ml avec aiguille(s)
- ENGERIX B 20 microgrammes/1 mL, suspension injectable en seringue préremplie. Vaccin de l'hépatite B (ADNr), (adsorbé) (VHB)
- ANTIGÈNE DE SURFACE DE L'HÉPATITE B RECOMBINANT
Complete source data
{
"cis": "62279329",
"cip7": "3516690",
"form": "suspension injectable",
"name": "ENGERIX B 20 microgrammes/1 mL, suspension injectable en seringue préremplie. Vaccin de l'hépatite B (ADNr), (adsorbé) (VHB) — 1 seringue(s) préremplie(s) en verre de 1 ml avec aiguille(s)",
"cip13": "3400935166906",
"holder": "GLAXOSMITHKLINE",
"routes": [
"intramusculaire",
"sous-cutanée"
],
"holders": [
"GLAXOSMITHKLINE"
],
"currency": "EUR",
"marketed": true,
"bdmStatus": null,
"useDomain": "unknown",
"publicPrice": "16.81",
"authorisedOn": "1994-12-30",
"compositions": [
{
"name": "ANTIGÈNE DE SURFACE DE L'HÉPATITE B RECOMBINANT",
"nature": "SA",
"strength": "20 microgrammes",
"linkageNumber": "1",
"substanceCode": "09692",
"dosageReference": "une dose de 1 ml",
"pharmaceuticalElement": "suspension"
}
],
"sourceStatus": "Présentation active",
"supplyRegime": "liste I",
"dispensingFee": "1.02",
"medicinePrice": "15.79",
"regionalRules": "not-collected",
"targetSpecies": [],
"specialityName": "ENGERIX B 20 microgrammes/1 mL, suspension injectable en seringue préremplie. Vaccin de l'hépatite B (ADNr), (adsorbé) (VHB)",
"marketingStatus": "Déclaration de commercialisation",
"publicationDates": {
"CIS_bdpm": "2026-01-08",
"CIS_CIP_bdpm": "2026-11-19",
"CIS_CPD_bdpm": "2026-01-08",
"CIS_COMPO_bdpm": "2026-01-08"
},
"specialityListed": true,
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "fr.ansm.bdpm"
},
"collectiveApproval": "oui",
"packageDescription": "1 seringue(s) préremplie(s) en verre de 1 ml avec aiguille(s)",
"patientEligibility": "not-assessed",
"reimbursementRates": [
"65%"
],
"marketingDeclaredOn": "2001-04-15",
"targetSpeciesStatus": "not-reported",
"additionalMonitoring": false,
"administrativeStatus": "authorised",
"prescriptionCategory": "prescription-or-restricted",
"activeIngredientNames": [
"ANTIGÈNE DE SURFACE DE L'HÉPATITE B RECOMBINANT"
],
"authorisationProcedure": "Procédure de reconnaissance mutuelle",
"prescriptionConditions": [
"liste I"
],
"reimbursementIndications": null,
"authorisationSourceStatus": "Autorisation active",
"europeanAuthorisationNumber": null,
"presentationAdministrativeStatus": "authorised"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=fr" \
--data-urlencode "sourceId=fr.ansm.bdpm" \
--data-urlencode "id=fr:ansm:packages:3400935166906"